MHRA Board Conflicted to Hell and Back—Gates, Big Pharma, WHO, Microsoft, NHS—All Serving their Masters, not Patient Safety
Check out MHRA Board Declarations of Interest – May 2023
This will shock you to the core, no matter where you are
What follows below shocked me to the core, and may well do the same for you. I’ve long been banging on about the UK being the epicentre of Gates’ global healthcare and life science empire. Part of that is his ownership of the people that are on the MHRA Board….as non-executive directors. Subscribers can read more on that below:
MHRA changed the rules on manufacturing gene therapies—did UK Government know?
INSIDE PHARMA is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. UK Government wants to lead the world in pharmaceutical R&D We know from the document below that UK Government has a plan to lead the world in Life Sciences and pharmaceutical R&D:
The MHRA Board Declarations of Interest – May 2023 shines a spotlight on the degree of conflicted and vested interests there are on the Board. You may not be surprised to read the ‘disclaimer’.
The Board and its Non-Executive Directors have no involvement in any regulatory decisions affecting medicines, medical devices or any other products or services delivered by the Agency. These decisions are the responsibility of the Chief Executive Officer, supported by the Executive Co…